Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: A meta-analysis of randomized controlled trials

作者
Lei-zhi Shi,RUI HENG,Shimin Liu,FEI-YAN LENG
出处
期刊:Experimental and Therapeutic Medicine [Spandidos Publishing]
卷期号:10 (2): 816-822 被引量:56
标识
DOI:10.3892/etm.2015.2545
摘要

The aim of the present study was to compare the health outcomes of catheter ablation therapy against those of antiarrhythmic drugs (AADs) in the management of atrial fibrillation (AF). The effects of catheter ablation and AADs on a number of parameters were compared, including AF recurrence, all-cause mortality, stroke/transient ischemic attack (TIA) and quality of life (QoL). A systematic literature search of PubMed, Embase and the Cochrane Central Register of Controlled Trials was conducted to obtain relevant randomized controlled trials. The relative risks (RRs) and 95% confidence intervals (CIs) of AF recurrence, all-cause mortality and stroke/TIA between catheter ablation and AADs were subsequently calculated. Weighted mean differences (WMDs) and 95% CIs were used to evaluate the QoL between the two therapy groups. In total, 11 randomized trials, which included 1,763 AF patients, were eligible for the meta-analysis. Overall, the results indicated that catheter ablation produces superior outcomes compared with AADs in reducing AF recurrence (RR, 0.47; 95% CI, 0.38-0.58; P<0.001) and improving the QoL (physical component summary: WMD, 2.23; 95% CI, 0.24-4.21; P=0.03; mental component summary: WMD, 2.69; 95% CI, 0.04-5.35; P=0.05). However, no statistically significant difference was identified between the two groups with regard to the incidence of all-cause mortality (RR, 0.87; 95% CI, 0.37-2.06; P=0.76) and stroke/TIA (RR, 1.83; 95% CI, 0.73-4.55; P=0.20). In summary, catheter ablation was demonstrated to markedly reduce AF recurrence and improve QoL when compared with AAD therapy. However, the incidence rates of all-cause mortality and stroke/TIA were comparable between catheter ablation and AAD therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
传奇3的应助被科研通管家采纳,获得10
刚刚
liu完成签到,获得积分10
刚刚
英姑的应助被科研通管家采纳,获得10
刚刚
慕青的应助被科研通管家采纳,获得10
刚刚
衣兮完成签到,获得积分10
刚刚
张大诚完成签到,获得积分10
刚刚
怡然访云完成签到,获得积分10
刚刚
殷勤的紫槐的应助被科研通管家采纳,获得200
刚刚
小二郎的应助被科研通管家采纳,获得10
1秒前
英俊的铭的应助被科研通管家采纳,获得20
1秒前
呆毛完成签到,获得积分10
1秒前
1秒前
1秒前
邢至森完成签到,获得积分10
2秒前
马也发布了新的文献求助10
2秒前
微血管发布了新的文献求助10
2秒前
善良的采蓝完成签到,获得积分10
2秒前
马敬丽发布了新的文献求助10
2秒前
DARLING002完成签到,获得积分10
2秒前
3秒前
huyuan发布了新的文献求助10
4秒前
周周完成签到,获得积分10
4秒前
勤劳飞风完成签到,获得积分10
4秒前
4秒前
xiaoyu完成签到,获得积分10
4秒前
闵行机发布了新的文献求助20
4秒前
zhaosiqi完成签到,获得积分10
4秒前
sssane发布了新的文献求助10
4秒前
4秒前
zjzj完成签到,获得积分10
5秒前
5秒前
microbiome121完成签到,获得积分10
6秒前
优秀的映萱完成签到,获得积分10
6秒前
6秒前
way_oz发布了新的文献求助10
6秒前
cijing完成签到,获得积分10
7秒前
刘洋发布了新的文献求助10
7秒前
小马甲的应助被小剧场采纳,获得10
7秒前
biolong545发布了新的文献求助10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180407
求助须知:如何正确求助?哪些是违规求助? 9570403
关于积分的说明 21811831
捐赠科研通 7776452
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557499
邀请新用户注册赠送积分活动 2479105